. Author manuscript; available in PMC: 2017 Sep 1.

Published in final edited form as: Transl Res. 2016 Mar 31;175:103–115.e4. doi: 10.1016/j.trsl.2016.03.017

Table 5. Multiple Regression Analysis of acute GVHD (grades II-IV) at month 6 with Predicted F-ara-A Clearance (Clpred) in the Independent Cohort.

Variable	Hazard Ratio (95% CI) of acute GVHD (grade II-IV) at 180 days	P-value
F-ara-A Clpred
<13.0 L/hr	1.00
≥13.0 L/hr	0.44 (0.19-1.02)	0.05
Stem Cell Source
Related	1.00
Unrelated (UR)	1.76 (1.08-2.87)	0.02
UR Cord Blood	0.75 (0.69-1.66)	0.75